Vice President Ann Baker will moderate a session entitled “Covering all the bases: An integrated approach to strategic drug development.” John Cole will facilitate BIO-Europe’s Academic Innovators track, a series of presentations designed to bridge the gap and encourage collaboration between academia and the biopharma industry.
CRA is a silver sponsor and exhibitor for this annual conference. Visit us at booth #27.
For more information on this event, click here.
CRA's RADAR Insights: Impact of US pricing strategies on orphan drug pricing in Germany - Part 3
In Part 3 of this series, RADAR data on orphan-drug pricing in Germany revealed a significant increase in manufacturer-set list prices for new orphan drugs...